ID

23075

Beschrijving

Responsible Party: Fresenius Medical Care Deutschland GmbH ClinicalTrials.gov Identifier: NCT02769351 History of Changes Other Study ID Numbers: UF-HF-01-INT DRKS00009836 ( Registry Identifier: DRKS: German Clinical Trials Register ) Study First Received: March 21, 2016 Last Updated: August 15, 2016 Individual Participant Data Plan to Share IPD: No Plan Description: Overall results will be published. Individual participant data will not be made available. Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration (GENTLE-UF) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02769351

Link

https://clinicaltrials.gov/ct2/show/NCT02769351

Trefwoorden

  1. 22-06-17 22-06-17 -
Geüploaded op

22 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Less Invasive Ultrafiltration in Patients with Volume Overload DRKS00009836 NCT02769351 DRKS00009836

Eligibility Less Invasive Ultrafiltration in Patients with Volume Overload NCT02769351 DRKS00009836

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Ages Eligible for Study: 18 Years and older (Adult, Senior)
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Inpatient-treated patients with acute volume overload, preferably in association with cardiac decompensation with signs of incipient diuretic resistance (lack of increase in urine output despite significant escalation of diuretic therapy; e.g. ≥80 mg furosemide / 24 h or less than 1375 mL urine output/40 mg furosemide per 24 h or equivalent dose of other loop diuretics [established clinically or from the medical history])
Beschrijving

Fluid overload

Datatype

boolean

Alias
UMLS CUI [1]
C0546817
New York Association Functional Class (NYHA) III-IV at inclusion
Beschrijving

NYHA

Datatype

boolean

Alias
UMLS CUI [1]
C1275491
Systolic or diastolic cardiac dysfunction (HF-REF or HF-PEF)
Beschrijving

Cardiac dysfunction

Datatype

boolean

Alias
UMLS CUI [1]
C3277906
Adequate venous access (preferably peripheral arm vein) allowing a flow rate ≥ 60 mL / min
Beschrijving

Venous access

Datatype

boolean

Alias
UMLS CUI [1]
C0750164
Written consent to the use of data in the registry (where necessary, by a legal guardian).
Beschrijving

Informed Consent

Datatype

text

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Healthy Volunteers
Beschrijving

Control Group

Datatype

boolean

Alias
UMLS CUI [1]
C0009932
Contraindication to anticoagulation (e.g. known heparin-induced thrombocytopenia, severe bleeding)
Beschrijving

Contraindication to anticoagulation

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0449867
Terminal renal failure (stage V, GFR <15 mL)
Beschrijving

GFR

Datatype

text

Alias
UMLS CUI [1]
C0017654
Cardiogenic shock, e.g. in association with acute coronary syndrome (ACS)
Beschrijving

Cardiogenic shock

Datatype

boolean

Alias
UMLS CUI [1]
C0036980
Other diseases or factors that, in the study doctor's opinion, constitute a potential contraindication to ultrafiltration
Beschrijving

Comorbidity

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
Pregnant women, women in labour, breast-feeding women or women of childbearing potential, who are without adequate contraception or are planning a family. NB: a pregnancy test is performed systematically in women of childbearing age and the patient is not included in the event of pregnancy (positive test). It is absolutely essential that women, who have a negative test and who are included in the study, have an effective contraception.
Beschrijving

Contraceptive Methods

Datatype

boolean

Alias
UMLS CUI [1]
C0700589

Similar models

Eligibility Less Invasive Ultrafiltration in Patients with Volume Overload NCT02769351 DRKS00009836

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
Ages Eligible for Study: 18 Years and older (Adult, Senior)
boolean
C0001779 (UMLS CUI [1])
Fluid overload
Item
Inpatient-treated patients with acute volume overload, preferably in association with cardiac decompensation with signs of incipient diuretic resistance (lack of increase in urine output despite significant escalation of diuretic therapy; e.g. ≥80 mg furosemide / 24 h or less than 1375 mL urine output/40 mg furosemide per 24 h or equivalent dose of other loop diuretics [established clinically or from the medical history])
boolean
C0546817 (UMLS CUI [1])
NYHA
Item
New York Association Functional Class (NYHA) III-IV at inclusion
boolean
C1275491 (UMLS CUI [1])
Cardiac dysfunction
Item
Systolic or diastolic cardiac dysfunction (HF-REF or HF-PEF)
boolean
C3277906 (UMLS CUI [1])
Venous access
Item
Adequate venous access (preferably peripheral arm vein) allowing a flow rate ≥ 60 mL / min
boolean
C0750164 (UMLS CUI [1])
Informed Consent
Item
Written consent to the use of data in the registry (where necessary, by a legal guardian).
text
C0021430 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Contraindication to anticoagulation
Item
Contraindication to anticoagulation (e.g. known heparin-induced thrombocytopenia, severe bleeding)
boolean
C1301624 (UMLS CUI [1,1])
C0449867 (UMLS CUI [1,2])
GFR
Item
Terminal renal failure (stage V, GFR <15 mL)
text
C0017654 (UMLS CUI [1])
Cardiogenic shock
Item
Cardiogenic shock, e.g. in association with acute coronary syndrome (ACS)
boolean
C0036980 (UMLS CUI [1])
Comorbidity
Item
Other diseases or factors that, in the study doctor's opinion, constitute a potential contraindication to ultrafiltration
boolean
C0009488 (UMLS CUI [1])
Contraceptive Methods
Item
Pregnant women, women in labour, breast-feeding women or women of childbearing potential, who are without adequate contraception or are planning a family. NB: a pregnancy test is performed systematically in women of childbearing age and the patient is not included in the event of pregnancy (positive test). It is absolutely essential that women, who have a negative test and who are included in the study, have an effective contraception.
boolean
C0700589 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial